Facemask Testing
One of the main factors influencing the amount of inhaled drug available to the patient is the interface between the facemask and the patient. Investigating and defining the effect of a facemask to the product’s DDU and APSD is important for the product development.
Facemask Stand FMS
View BrochureFMS to NGI Interface Accessory
View BrochureAdult/Child/Infant Face Model
View BrochureFilter Adapter and Holder
View BrochureNext Generation Impactor NGI
View BrochureNGI Induction Port
View BrochureBreathing Simulator BRS 100i
View ProductBreath Actuation Controller BAC 100i
View ProductAPSD of Nebulisers
View SystemDDU
View SystemFacemask Stand FMS
View BrochureFMS to NGI Interface Accessory
View BrochureAdult/Child/Infant Face Model
View BrochureFilter Adapter and Holder
View BrochureNext Generation Impactor NGI
View BrochureNGI Induction Port
View BrochureBreathing Simulator BRS 100i
View ProductBreath Actuation Controller BAC 100i
View ProductAPSD of Nebulisers
View SystemDDU
View SystemRelated Services

Training
We offer a range of training courses, presentations and seminars covering a wide range of topics.
Find Out More
Servicing
A comprehensive range of both in-house and on-site product servicing options are available
Find Out More
Support
Our team of experienced technicians and engineers are on hand to help and advise
Find Out MoreRelated News & Resources

Introducing the Copley Impactor Genie™ IG 200i, a two-in-one solution for quicker, more efficient inhaled product testing
25th April 2023; Nottingham, UK: The new Impactor Genie™ IG 200i from Copley Scientific is a cost- and space-efficient semi-automation tool for regulatory and…
Find Out More
Copley Scientific joins the Industries Forum of the Taskforce for Lung Health
23 June 2021; Nottingham, UK: Copley Scientific has joined the Industries Forum of the Taskforce for Lung Health. The Taskforce is a collaboration of over…
Find Out More
Introducing Inhalytix™: a new solution for analysing and managing inhaler test data from Copley
18 March 2021; Nottingham, UK: Inhalytix™ is a completely new software solution from Copley, the global leader in inhaler testing equipment, that brings a…
Find Out More
Copley announces a major upgrade of the world’s ‘go to’ inhaler testing portfolio
01 March 2021, Nottingham, UK: Copley Scientific, the global leaders in inhaler testing equipment, is marking the company’s 75th anniversary with a significant upgrade…
Find Out More
New e-Training service from Copley for pharmaceutical testing
14 January 2021; Nottingham, UK: Copley Scientific is now delivering e-Training, offering customers across the globe remote access to expert tuition on in vitro…
Find Out More
Copley Scientific releases new accessories for testing nebulisers with facemasks
31 May 2018; Nottingham, UK: New accessories from Copley Scientific simplify the rigorous investigation of how a facemask impacts potential critical quality attributes of…
Find Out More
Copley Scientific previews new apparatus for metered dose inhaler testing at DDL 25
11 November 2014; Nottingham, UK: Copley Scientific will be displaying the smart new Facemask Testing Apparatus for metered-dose inhaler (MDI) testing, in accordance with…
Find Out More
PMPS Q&A (Samedan): April 2021
Putting Inhalers to the Test Anna Sipitanou has worked for Copley Scientific for four years, expanding her drug discovery and pharma science background. She…
Find Out More
Microbioz India: February 2021
A short Q&A with our CEO, Mark Copley, on inhaled product testing
Find Out More
Drug Development & Delivery Article: April 2018
Optimizing the Application of In Vitro Test Methods for the Demonstration of Bioequivalence in Orally Inhaled Products
Find Out More
PMPS Article (Samedan): February 2018
Demonstrating Bioequivalence of Orally Inhaled Products Safe and cost-effective treatments for respiratory diseases are facing a growing demand. The demonstration of bioequivalence within locally…
Find Out More
White Paper: February 2018
Optimising the application of in vitro test methods for the demonstration of BE in OIPs
Find Out More
American Pharmaceutical Review Article: Nov/Dec 2017
Characterizing the Performance of Metered Dose Inhalers with Add-On Devices: New Methods For Clinically Relevant Testing
Find Out MoreHave a question? Our friendly and experienced team are here to help.